Aggressive behavior and the motivation to act aggressively have distinct molecular bases, each involving the same reward-associated transcription factor, but different types of neurons
Pfenex won a National Institute of Allergy and Infectious Diseases (NIAID) contract worth an initial $2.18 million to support development of a dry formulation of the firm’s Pfenex-rPA (recombinant protective antigen) anthrax vaccine that will be suitable for needle-free delivery and stable for long-term storage.
The collaboration is intended to generate constant Fc-domains with antigen-binding activity (FcabsTM) that can bind to transporters in the blood–brain barrier
The Goji Berry “superfruit” is a source of a potential treatment against the parasites that cause schistosomiasis and fasciolosis
Firm is exploiting platform to develop blood-based DNA assays for disease diagnosis and monitoring.
Company lays off 30 and shuts down its U.S. offices in San Bruno, CA, two weeks after Rospitor fails Phase III trial in patients with interstitial cystitis/bladder pain syndrome.
Also, in December 2009, Aegis signed a licensing agreement with Roche, giving the latter access to its ProTek technology.
90,000 sq. ft. facility is to be built for the manufacture of 10 million doses/month.
Please wait while you are redirected to the right page...